Daiichi Sankyo Co Limited Sponsored Adr News, Daiichi Sankyo Co Limited Sponsored Adr Quote, DSNKY Quote

Daiichi Sankyo Co Limited Sponsored Adr (OP:DSNKY) Delayed: 15.63 --15.63 (-0%)

Prev. Close

$0.00

Today 6M 1Y 5Y

Open

$0.00

52 Wk High

$26.24

52 Wk Low

$18.86

Day High

$15.70

Day Low

$15.63

P/E

N/A

EPS

$0.00

Volume

1,886

Friends, Peers and Foes (?): AZN, 4568:JP, MRK, CGEN NUVB (more...)

ALERTS | RSS

Jun 3, 2026 09:24 AM JPMorgan Downgrades Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) to Neutral
May 28, 2026 07:00 AM Daiichi Sankyo Showcases Progress Across Industry-Leading Oncology Portfolio with Latest Research Updates at ASCO
May 26, 2026 11:00 AM Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 2026
May 22, 2026 09:30 AM Datroway® Approved in the U.S. as First TROP2 Directed Antibody Drug Conjugate for First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Cand
May 22, 2026 08:00 AM Enhertu gets EU panel backing for HER2 positive metastatic solid tumors
May 22, 2026 08:00 AM Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors
May 15, 2026 06:31 PM Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer
May 12, 2026 06:40 AM Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) PT Lowered to JPY5,500 at Macquarie
May 11, 2026 02:30 AM Daiichi Sankyo Unveils New Five-Year Business Plan Focused on Oncology Leadership and Innovation
Apr 28, 2026 05:02 AM Macquarie Reiterates Outperform Rating on Daiichi Sankyo Company, Limited (4568:JP) (DSNKY)

Entities mentioned with DSNKY

View All Entities